GPCR Conference: ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’
News Jul 14, 2009
Taking place at The Nucleus conference centre, Chesterford Research Park, Saffron Walden, UK from 22 - 23 September 2009, the new scientific conference ‘Novel Applications and Cutting Edge Technologies for GPCR Screening and Profiling’ will provide delegates with the opportunity to hear from thought leaders and share experiences within this field.
Keynote speaker Fiona Marshall, Chief Scientific Officer, Heptares Therapeutics, will talk about “Structure-based Drug Discovery for GPCR Targets”.
The meeting will highlight the latest technological developments and tools available for drug discovery on GPCR receptors, with key opinion leaders presenting their experience of generating high-quality screening data.
Furthermore, case studies will be described where flexible assay formats and newly available tools have enhanced throughput for successful compound screening.
This meeting is being sponsored by three pioneering companies in GPCR research, BioFocus DPI, DiscoveRx and MDS Analytical Technologies.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE